| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | arachidonate epoxygenase activity | 1.47e-08 | 24 | 143 | 6 | GO:0008392 | |
| GeneOntologyMolecularFunction | arachidonate monooxygenase activity | 3.17e-08 | 27 | 143 | 6 | GO:0008391 | |
| GeneOntologyMolecularFunction | aromatase activity | 1.66e-07 | 35 | 143 | 6 | GO:0070330 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 1.32e-06 | 49 | 143 | 6 | GO:0016712 | |
| GeneOntologyMolecularFunction | linoleic acid epoxygenase activity | 1.43e-06 | 4 | 143 | 3 | GO:0071614 | |
| GeneOntologyMolecularFunction | retinoic acid 4-hydroxylase activity | 2.39e-06 | 14 | 143 | 4 | GO:0008401 | |
| GeneOntologyMolecularFunction | ATP-dependent protein folding chaperone | 9.44e-06 | 40 | 143 | 5 | GO:0140662 | |
| GeneOntologyMolecularFunction | protein folding chaperone | 1.39e-05 | 73 | 143 | 6 | GO:0044183 | |
| GeneOntologyMolecularFunction | monooxygenase activity | 1.92e-05 | 115 | 143 | 7 | GO:0004497 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor | 1.96e-05 | 8 | 143 | 3 | GO:0033695 | |
| GeneOntologyMolecularFunction | caffeine oxidase activity | 1.96e-05 | 8 | 143 | 3 | GO:0034875 | |
| GeneOntologyMolecularFunction | heat shock protein binding | 2.32e-05 | 163 | 143 | 8 | GO:0031072 | |
| GeneOntologyMolecularFunction | iron ion binding | 2.64e-05 | 166 | 143 | 8 | GO:0005506 | |
| GeneOntologyMolecularFunction | (R)-limonene 6-monooxygenase activity | 5.09e-05 | 2 | 143 | 2 | GO:0052741 | |
| GeneOntologyMolecularFunction | (S)-limonene 6-monooxygenase activity | 5.09e-05 | 2 | 143 | 2 | GO:0018675 | |
| GeneOntologyMolecularFunction | (S)-limonene 7-monooxygenase activity | 5.09e-05 | 2 | 143 | 2 | GO:0018676 | |
| GeneOntologyMolecularFunction | limonene monooxygenase activity | 5.09e-05 | 2 | 143 | 2 | GO:0019113 | |
| GeneOntologyMolecularFunction | estrogen 16-alpha-hydroxylase activity | 5.69e-05 | 11 | 143 | 3 | GO:0101020 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 7.98e-05 | 194 | 143 | 8 | GO:0016705 | |
| GeneOntologyMolecularFunction | steroid hydroxylase activity | 9.90e-05 | 34 | 143 | 4 | GO:0008395 | |
| GeneOntologyMolecularFunction | denatured protein binding | 1.52e-04 | 3 | 143 | 2 | GO:0031249 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups | 1.54e-04 | 15 | 143 | 3 | GO:0016725 | |
| GeneOntologyMolecularFunction | arachidonate 11,12-epoxygenase activity | 3.03e-04 | 4 | 143 | 2 | GO:0008405 | |
| GeneOntologyMolecularFunction | fatty acid omega-1 hydroxylase activity | 5.02e-04 | 5 | 143 | 2 | GO:0120502 | |
| GeneOntologyMolecularFunction | long-chain fatty acid omega-1 hydroxylase activity | 5.02e-04 | 5 | 143 | 2 | GO:0120319 | |
| GeneOntologyMolecularFunction | death receptor agonist activity | 5.02e-04 | 5 | 143 | 2 | GO:0038177 | |
| GeneOntologyMolecularFunction | arachidonate 14,15-epoxygenase activity | 5.02e-04 | 5 | 143 | 2 | GO:0008404 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase binding | 6.52e-04 | 24 | 143 | 3 | GO:0120283 | |
| GeneOntologyMolecularFunction | ATP-dependent protein disaggregase activity | 7.50e-04 | 6 | 143 | 2 | GO:0140545 | |
| GeneOntologyMolecularFunction | C3HC4-type RING finger domain binding | 7.50e-04 | 6 | 143 | 2 | GO:0055131 | |
| GeneOntologyMolecularFunction | heme binding | 8.56e-04 | 154 | 143 | 6 | GO:0020037 | |
| GeneOntologyMolecularFunction | tetrapyrrole binding | 1.18e-03 | 164 | 143 | 6 | GO:0046906 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 1.40e-03 | 231 | 143 | 7 | GO:0005085 | |
| GeneOntologyMolecularFunction | transition metal ion binding | TRIM72 CYP2B6 CYP2C19 CYP2C8 CYP2C9 CYP2C18 CYP2F1 ALKBH2 DTNA FTMT TRIM77 DBH TXNRD1 ZMAT3 OTUD7A KMT2A UTRN RNF207 | 2.12e-03 | 1189 | 143 | 18 | GO:0046914 |
| GeneOntologyMolecularFunction | unfolded protein binding | 2.14e-03 | 126 | 143 | 5 | GO:0051082 | |
| GeneOntologyMolecularFunction | oxygen binding | 2.34e-03 | 37 | 143 | 3 | GO:0019825 | |
| GeneOntologyMolecularFunction | disordered domain specific binding | 2.72e-03 | 39 | 143 | 3 | GO:0097718 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor | 3.21e-03 | 12 | 143 | 2 | GO:0052890 | |
| GeneOntologyMolecularFunction | acyl-CoA dehydrogenase activity | 3.21e-03 | 12 | 143 | 2 | GO:0003995 | |
| GeneOntologyMolecularFunction | oxidoreductase activity | CYP2B6 CYP2C19 CYP2C8 CYP2C9 CYP2C18 CYP2F1 ALKBH2 GCDH FTMT DBH ACAD10 TXNRD1 HADHB | 3.46e-03 | 766 | 143 | 13 | GO:0016491 |
| GeneOntologyBiologicalProcess | epoxygenase P450 pathway | 7.10e-09 | 22 | 144 | 6 | GO:0019373 | |
| GeneOntologyBiologicalProcess | protein refolding | 1.92e-06 | 30 | 144 | 5 | GO:0042026 | |
| GeneOntologyBiologicalProcess | chaperone cofactor-dependent protein refolding | 4.24e-06 | 35 | 144 | 5 | GO:0051085 | |
| GeneOntologyBiologicalProcess | cellular heat acclimation | 6.56e-06 | 6 | 144 | 3 | GO:0070370 | |
| GeneOntologyBiologicalProcess | arachidonate metabolic process | 8.00e-06 | 68 | 144 | 6 | GO:0019369 | |
| GeneOntologyBiologicalProcess | 'de novo' post-translational protein folding | 9.47e-06 | 41 | 144 | 5 | GO:0051084 | |
| GeneOntologyBiologicalProcess | heat acclimation | 1.14e-05 | 7 | 144 | 3 | GO:0010286 | |
| GeneOntologyBiologicalProcess | 'de novo' protein folding | 1.68e-05 | 46 | 144 | 5 | GO:0006458 | |
| GeneOntologyBiologicalProcess | regulation of ARF protein signal transduction | 1.82e-05 | 23 | 144 | 4 | GO:0032012 | |
| GeneOntologyBiologicalProcess | chaperone-mediated protein folding | 2.05e-05 | 80 | 144 | 6 | GO:0061077 | |
| GeneOntologyBiologicalProcess | ARF protein signal transduction | 2.17e-05 | 24 | 144 | 4 | GO:0032011 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 6.05e-05 | 141 | 144 | 7 | GO:0006805 | |
| GeneOntologyBiologicalProcess | omega-hydroxylase P450 pathway | 1.15e-04 | 14 | 144 | 3 | GO:0097267 | |
| GeneOntologyBiologicalProcess | xenobiotic catabolic process | 1.26e-04 | 37 | 144 | 4 | GO:0042178 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid metabolic process | 2.37e-04 | 124 | 144 | 6 | GO:0001676 | |
| GeneOntologyBiologicalProcess | unsaturated fatty acid metabolic process | 2.81e-04 | 128 | 144 | 6 | GO:0033559 | |
| GeneOntologyCellularComponent | COP9 signalosome | 1.29e-04 | 38 | 143 | 4 | GO:0008180 | |
| GeneOntologyCellularComponent | aggresome | 1.58e-04 | 40 | 143 | 4 | GO:0016235 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | IQSEC3 IQSEC2 PSD3 BACE1 MPDZ LRRTM3 ACTN2 SLC8A2 GRID2IP IQSEC1 NLGN2 KCNT1 | 2.59e-04 | 523 | 143 | 12 | GO:0098984 |
| GeneOntologyCellularComponent | postsynaptic density, intracellular component | 3.50e-04 | 49 | 143 | 4 | GO:0099092 | |
| GeneOntologyCellularComponent | inclusion body | 3.85e-04 | 90 | 143 | 5 | GO:0016234 | |
| GeneOntologyCellularComponent | postsynaptic specialization, intracellular component | 5.85e-04 | 56 | 143 | 4 | GO:0099091 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 6.46e-04 | 25 | 143 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | postsynaptic specialization | IQSEC3 IQSEC2 PSD3 MPDZ LRRTM3 ACTN2 SLC8A2 GRID2IP IQSEC1 NLGN2 KCNT1 | 6.99e-04 | 503 | 143 | 11 | GO:0099572 |
| GeneOntologyCellularComponent | postsynaptic density | IQSEC3 IQSEC2 PSD3 MPDZ LRRTM3 ACTN2 SLC8A2 GRID2IP IQSEC1 KCNT1 | 1.10e-03 | 451 | 143 | 10 | GO:0014069 |
| MousePheno | increased circulating LDL cholesterol level | 4.58e-07 | 80 | 122 | 8 | MP:0000182 | |
| Domain | INT_SG_DDX_CT_C | 1.30e-09 | 8 | 142 | 5 | PF15300 | |
| Domain | INT_SG_DDX_CT_C | 1.30e-09 | 8 | 142 | 5 | IPR029307 | |
| Domain | HSP70 | 9.67e-08 | 16 | 142 | 5 | PF00012 | |
| Domain | HSP70_2 | 1.36e-07 | 17 | 142 | 5 | PS00329 | |
| Domain | HSP70_1 | 1.36e-07 | 17 | 142 | 5 | PS00297 | |
| Domain | HSP70_3 | 1.36e-07 | 17 | 142 | 5 | PS01036 | |
| Domain | Hsp_70_fam | 1.87e-07 | 18 | 142 | 5 | IPR013126 | |
| Domain | Cyt_P450_E_grp-I_CYP2B-like | 4.30e-07 | 3 | 142 | 3 | IPR008068 | |
| Domain | IQSEC_PH | 4.30e-07 | 3 | 142 | 3 | IPR033742 | |
| Domain | IQ_SEC7_PH | 4.30e-07 | 3 | 142 | 3 | PF16453 | |
| Domain | Cyt_P450_E_grp-I | 1.11e-06 | 45 | 142 | 6 | IPR002401 | |
| Domain | - | 1.51e-06 | 12 | 142 | 4 | 2.60.34.10 | |
| Domain | HSP70_peptide-bd | 1.51e-06 | 12 | 142 | 4 | IPR029047 | |
| Domain | - | 2.17e-06 | 13 | 142 | 4 | 1.20.1270.10 | |
| Domain | Heat_shock_70_CS | 2.17e-06 | 13 | 142 | 4 | IPR018181 | |
| Domain | HSP70_C | 2.17e-06 | 13 | 142 | 4 | IPR029048 | |
| Domain | Cyt_P450_CS | 2.97e-06 | 53 | 142 | 6 | IPR017972 | |
| Domain | - | 4.10e-06 | 15 | 142 | 4 | 1.10.1000.11 | |
| Domain | Sec7 | 4.10e-06 | 15 | 142 | 4 | PF01369 | |
| Domain | Sec7_alpha_orthog | 4.10e-06 | 15 | 142 | 4 | IPR023394 | |
| Domain | CYTOCHROME_P450 | 4.58e-06 | 57 | 142 | 6 | PS00086 | |
| Domain | - | 5.08e-06 | 58 | 142 | 6 | 1.10.630.10 | |
| Domain | p450 | 5.08e-06 | 58 | 142 | 6 | PF00067 | |
| Domain | SEC7 | 5.43e-06 | 16 | 142 | 4 | PS50190 | |
| Domain | Sec7 | 5.43e-06 | 16 | 142 | 4 | SM00222 | |
| Domain | Sec7_dom | 5.43e-06 | 16 | 142 | 4 | IPR000904 | |
| Domain | Cyt_P450 | 6.20e-06 | 60 | 142 | 6 | IPR001128 | |
| Domain | RmlC_Cupin | 2.24e-04 | 16 | 142 | 3 | IPR011051 | |
| Domain | Haem_d1 | 8.44e-04 | 6 | 142 | 2 | IPR011048 | |
| Domain | EF-hand_dom_typ1 | 8.44e-04 | 6 | 142 | 2 | IPR015153 | |
| Domain | EF-hand_dom_typ2 | 8.44e-04 | 6 | 142 | 2 | IPR015154 | |
| Domain | EF-hand_2 | 8.44e-04 | 6 | 142 | 2 | PF09068 | |
| Domain | EF-hand_3 | 8.44e-04 | 6 | 142 | 2 | PF09069 | |
| Domain | TPR-contain_dom | 1.01e-03 | 150 | 142 | 6 | IPR013026 | |
| Domain | CARD | 1.23e-03 | 28 | 142 | 3 | PF00619 | |
| Domain | DHC_N1 | 1.56e-03 | 8 | 142 | 2 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 1.56e-03 | 8 | 142 | 2 | IPR013594 | |
| Domain | TPR_REGION | 1.65e-03 | 165 | 142 | 6 | PS50293 | |
| Domain | TPR | 1.65e-03 | 165 | 142 | 6 | PS50005 | |
| Domain | CARD | 1.65e-03 | 31 | 142 | 3 | IPR001315 | |
| Domain | CARD | 1.99e-03 | 33 | 142 | 3 | PS50209 | |
| Pathway | REACTOME_CYP2E1_REACTIONS | 9.29e-09 | 11 | 105 | 5 | M27130 | |
| Pathway | REACTOME_XENOBIOTICS | 1.35e-08 | 23 | 105 | 6 | M5372 | |
| Pathway | KEGG_ENDOCYTOSIS | IQSEC3 IQSEC2 PSD3 SMURF1 AP2A2 IQSEC1 HSPA1A HSPA1B HSPA1L HSPA6 | 9.55e-07 | 181 | 105 | 10 | M1519 |
| Pathway | REACTOME_XENOBIOTICS | 9.83e-07 | 25 | 105 | 5 | MM14846 | |
| Pathway | REACTOME_CYP2E1_REACTIONS | 1.37e-06 | 12 | 105 | 4 | MM14847 | |
| Pathway | WP_OXIDATION_BY_CYTOCHROME_P450 | 6.48e-06 | 62 | 105 | 6 | M39653 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 7.81e-06 | 64 | 105 | 6 | M5650 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 1.32e-05 | 70 | 105 | 6 | M16794 | |
| Pathway | REACTOME_SYNTHESIS_OF_EPOXY_EET_AND_DIHYDROXYEICOSATRIENOIC_ACIDS_DHET | 2.19e-05 | 8 | 105 | 3 | M27135 | |
| Pathway | REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE | 3.26e-05 | 9 | 105 | 3 | M27143 | |
| Pathway | REACTOME_ATTENUATION_PHASE | 5.19e-05 | 28 | 105 | 4 | M27254 | |
| Pathway | KEGG_LINOLEIC_ACID_METABOLISM | 5.98e-05 | 29 | 105 | 4 | M2920 | |
| Pathway | KEGG_ARACHIDONIC_ACID_METABOLISM | 6.98e-05 | 58 | 105 | 5 | M5410 | |
| Pathway | REACTOME_HSF1_ACTIVATION | 7.83e-05 | 31 | 105 | 4 | M27252 | |
| Pathway | WP_VALPROIC_ACID_PATHWAY | 8.41e-05 | 12 | 105 | 3 | M39371 | |
| Pathway | WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID | 8.41e-05 | 12 | 105 | 3 | M48064 | |
| Pathway | REACTOME_ATTENUATION_PHASE | 1.09e-04 | 13 | 105 | 3 | MM14952 | |
| Pathway | KEGG_RETINOL_METABOLISM | 1.12e-04 | 64 | 105 | 5 | M9488 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 1.24e-04 | 104 | 105 | 6 | M738 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 1.30e-04 | 66 | 105 | 5 | MM14839 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES | 1.38e-04 | 14 | 105 | 3 | MM15842 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 1.77e-04 | 38 | 105 | 4 | M27255 | |
| Pathway | WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY | 1.84e-04 | 71 | 105 | 5 | M39690 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 1.96e-04 | 72 | 105 | 5 | M9257 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 3.61e-04 | 82 | 105 | 5 | M27250 | |
| Pathway | KEGG_SPLICEOSOME | 3.69e-04 | 127 | 105 | 6 | M2044 | |
| Pathway | WP_TAMOXIFEN_METABOLISM | 4.84e-04 | 21 | 105 | 3 | M39631 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 5.98e-04 | 52 | 105 | 4 | MM14949 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 6.38e-04 | 23 | 105 | 3 | MM14953 | |
| Pathway | WP_ESTROGEN_METABOLISM_WP5276 | 7.25e-04 | 24 | 105 | 3 | M46445 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_MARESIN_LIKE_SPMS | 8.08e-04 | 6 | 105 | 2 | M27909 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 8.48e-04 | 57 | 105 | 4 | M27251 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 9.37e-04 | 101 | 105 | 5 | M27253 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 1.12e-03 | 105 | 105 | 5 | MM14842 | |
| Pathway | WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE | 1.13e-03 | 7 | 105 | 2 | M39515 | |
| Pathway | REACTOME_SYNTHESIS_OF_EPOXY_EET_AND_DIHYDROXYEICOSATRIENOIC_ACIDS_DHET | 1.13e-03 | 7 | 105 | 2 | MM14856 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_MARESINS | 1.49e-03 | 8 | 105 | 2 | M27891 | |
| Pathway | WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY | 1.55e-03 | 31 | 105 | 3 | M39476 | |
| Pubmed | Identification of cancer/testis-antigen genes by massively parallel signature sequencing. | CT45A6 CT45A1 CT45A10 CT45A2 CT45A7 CT45A9 CT45A8 CT45A3 CT45A5 | 1.86e-18 | 15 | 149 | 9 | 15905330 |
| Pubmed | Biochemistry and molecular biology of the human CYP2C subfamily. | 3.24e-10 | 4 | 149 | 4 | 7704034 | |
| Pubmed | 3.24e-10 | 4 | 149 | 4 | 19706858 | ||
| Pubmed | 3.24e-10 | 4 | 149 | 4 | 2009263 | ||
| Pubmed | 3.24e-10 | 4 | 149 | 4 | 21798861 | ||
| Pubmed | 3.24e-10 | 4 | 149 | 4 | 23755828 | ||
| Pubmed | Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions. | 6.10e-10 | 11 | 149 | 5 | 16538176 | |
| Pubmed | Novel DNA sequence variations of cytochrome P450 genes in the Han Chinese population. | 2.62e-09 | 14 | 149 | 5 | 19290787 | |
| Pubmed | Genetic aspects of the hsp70 multigene family in vertebrates. | 4.82e-09 | 6 | 149 | 4 | 7988674 | |
| Pubmed | Molecular genetics of the human cytochrome P450 monooxygenase superfamily. | 1.99e-08 | 20 | 149 | 5 | 9890157 | |
| Pubmed | 4.01e-08 | 9 | 149 | 4 | 21763498 | ||
| Pubmed | Specific incorporation of heat shock protein 70 family members into primate lentiviral virions. | 6.66e-08 | 10 | 149 | 4 | 11932435 | |
| Pubmed | 6.66e-08 | 10 | 149 | 4 | 12832005 | ||
| Pubmed | 6.66e-08 | 10 | 149 | 4 | 7906708 | ||
| Pubmed | 6.66e-08 | 10 | 149 | 4 | 19651758 | ||
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 26496868 | ||
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 23666708 | ||
| Pubmed | The human CYP2C locus: a prototype for intergenic and exon repetition splicing events. | 7.71e-08 | 3 | 149 | 3 | 10704292 | |
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 23834474 | ||
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 24061851 | ||
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 19085089 | ||
| Pubmed | Heat shock protein 70 gene polymorphisms in Mexican patients with spondyloarthropathies. | 7.71e-08 | 3 | 149 | 3 | 11779758 | |
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 19439993 | ||
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 35134542 | ||
| Pubmed | Is preeclampsia associated with higher frequency of HSP70 gene polymorphisms? | 7.71e-08 | 3 | 149 | 3 | 16202503 | |
| Pubmed | Heat-shock protein-70 genes and response to antidepressants in major depression. | 7.71e-08 | 3 | 149 | 3 | 17428599 | |
| Pubmed | Polymorphisms of heat shock protein 70 gene (HSPA1A, HSPA1B and HSPA1L) and schizophrenia. | 7.71e-08 | 3 | 149 | 3 | 15963589 | |
| Pubmed | Heat shock protein 70 gene polymorphisms in sudden sensorineural hearing loss. | 7.71e-08 | 3 | 149 | 3 | 22922572 | |
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 15165109 | ||
| Pubmed | Distribution of CYP2C polymorphisms in an Amerindian population of Brazil. | 7.71e-08 | 3 | 149 | 3 | 21977947 | |
| Pubmed | A prospective evaluation of the heat shock protein 70 gene polymorphisms and the risk of stroke. | 7.71e-08 | 3 | 149 | 3 | 12008944 | |
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 16333988 | ||
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 23118231 | ||
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 23893339 | ||
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 19840767 | ||
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 28687336 | ||
| Pubmed | Chromosomal location of human genes encoding major heat-shock protein HSP70. | 7.71e-08 | 3 | 149 | 3 | 3470951 | |
| Pubmed | A 2.4-megabase physical map spanning the CYP2C gene cluster on chromosome 10q24. | 7.71e-08 | 3 | 149 | 3 | 8530044 | |
| Pubmed | Heat-shock protein gene polymorphisms and the risk of nephropathy in patients with Type 2 diabetes. | 7.71e-08 | 3 | 149 | 3 | 18518860 | |
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 19351530 | ||
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 21173785 | ||
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 15102943 | ||
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 2880793 | ||
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 20012387 | ||
| Pubmed | Analysis of the heat shock protein 70 (HSP70) genetic variants in nonsegmental vitiligo patients. | 7.71e-08 | 3 | 149 | 3 | 36345598 | |
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 24430292 | ||
| Pubmed | Structure and expression of the three MHC-linked HSP70 genes. | 7.71e-08 | 3 | 149 | 3 | 1700760 | |
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 20665013 | ||
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 27803446 | ||
| Pubmed | Heat shock protein 70 gene polymorphism in Japanese patients with multiple sclerosis. | 7.71e-08 | 3 | 149 | 3 | 11696222 | |
| Pubmed | Pharmacogenetics of cyclophosphamide in patients with hematological malignancies. | 7.71e-08 | 3 | 149 | 3 | 16183265 | |
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 16338275 | ||
| Pubmed | Characterisation of CYP2C8, CYP2C9 and CYP2C19 polymorphisms in a Ghanaian population. | 7.71e-08 | 3 | 149 | 3 | 19954515 | |
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 8095407 | ||
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 20704535 | ||
| Pubmed | Anti-inflammatory heat shock protein 70 genes are positively associated with human survival. | 7.71e-08 | 3 | 149 | 3 | 20388090 | |
| Pubmed | Human major histocompatibility complex contains genes for the major heat shock protein HSP70. | 7.71e-08 | 3 | 149 | 3 | 2538825 | |
| Pubmed | Analysis of heat-shock protein 70 gene polymorphisms and the risk of Parkinson's disease. | 7.71e-08 | 3 | 149 | 3 | 14605873 | |
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 9685725 | ||
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 17582394 | ||
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 28182740 | ||
| Pubmed | Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population. | 1.04e-07 | 11 | 149 | 4 | 15469410 | |
| Pubmed | 1.04e-07 | 11 | 149 | 4 | 15039299 | ||
| Pubmed | HIV-1 viral protein R (Vpr) and its interactions with host cell. | 1.56e-07 | 12 | 149 | 4 | 19275587 | |
| Pubmed | 1.56e-07 | 12 | 149 | 4 | 15319333 | ||
| Pubmed | 1.76e-07 | 30 | 149 | 5 | 20529763 | ||
| Pubmed | Variations in HSP70 genes associated with noise-induced hearing loss in two independent populations. | 3.07e-07 | 4 | 149 | 3 | 18813331 | |
| Pubmed | 3.07e-07 | 4 | 149 | 3 | 15248218 | ||
| Pubmed | 3.07e-07 | 4 | 149 | 3 | 28990182 | ||
| Pubmed | Association analysis of heat shock protein 70 gene polymorphisms in schizophrenia. | 3.07e-07 | 4 | 149 | 3 | 18299791 | |
| Pubmed | [Effect of HSP70 gene polymorphism on genetic susceptibility of pneumoconiosis of coal worker]. | 3.07e-07 | 4 | 149 | 3 | 20568452 | |
| Pubmed | Polymorphism of CYP2D6, CYP2C19, CYP2C9 and CYP2C8 in the Faroese population. | 3.07e-07 | 4 | 149 | 3 | 16025294 | |
| Pubmed | 3.07e-07 | 4 | 149 | 3 | 10768437 | ||
| Pubmed | Polymorphisms in the Hsp70 gene locus are genetically associated with systemic lupus erythematosus. | 3.07e-07 | 4 | 149 | 3 | 20498198 | |
| Pubmed | 3.13e-07 | 14 | 149 | 4 | 20970553 | ||
| Pubmed | 4.26e-07 | 15 | 149 | 4 | 10964507 | ||
| Pubmed | Interactome mapping suggests new mechanistic details underlying Alzheimer's disease. | 5.38e-07 | 111 | 149 | 7 | 21163940 | |
| Pubmed | Association of warfarin dose with genes involved in its action and metabolism. | 5.66e-07 | 16 | 149 | 4 | 17048007 | |
| Pubmed | Clathrin facilitates the morphogenesis of retrovirus particles. | 5.66e-07 | 16 | 149 | 4 | 21738476 | |
| Pubmed | 5.85e-07 | 70 | 149 | 6 | 15128046 | ||
| Pubmed | 7.66e-07 | 5 | 149 | 3 | 19415824 | ||
| Pubmed | 7.66e-07 | 5 | 149 | 3 | 19414633 | ||
| Pubmed | Association of cyclophosphamide pharmacokinetics to polymorphic cytochrome P450 2C19. | 7.66e-07 | 5 | 149 | 3 | 16116487 | |
| Pubmed | 7.66e-07 | 5 | 149 | 3 | 19106084 | ||
| Pubmed | Prevalence of CYP450 gene variations in patients with type 2 diabetes. | 7.66e-07 | 5 | 149 | 3 | 20857895 | |
| Pubmed | Pharmacogenetic testing for clopidogrel using the rapid INFINITI analyzer: a dose-escalation study. | 7.66e-07 | 5 | 149 | 3 | 19926050 | |
| Pubmed | 7.66e-07 | 5 | 149 | 3 | 7806281 | ||
| Pubmed | 7.66e-07 | 5 | 149 | 3 | 19626584 | ||
| Pubmed | 7.66e-07 | 5 | 149 | 3 | 17182002 | ||
| Pubmed | 7.66e-07 | 5 | 149 | 3 | 18024866 | ||
| Pubmed | 7.66e-07 | 5 | 149 | 3 | 19029318 | ||
| Pubmed | 1.13e-06 | 179 | 149 | 8 | 19074885 | ||
| Pubmed | A crucial role for Arf6 in the response of commissural axons to Slit. | 1.19e-06 | 19 | 149 | 4 | 30674481 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | PNN AUP1 BMS1 PRPF6 ELP3 ANKRD27 SERPINB6 DIMT1 AP2A2 CCDC47 IQSEC1 CTNNBL1 HADHB HSPA1L UTRN HSPA6 AP3D1 MED12 HSPA9 TOP2A | 1.46e-06 | 1353 | 149 | 20 | 29467282 |
| Pubmed | 1.53e-06 | 6 | 149 | 3 | 17900275 | ||
| Pubmed | 1.53e-06 | 6 | 149 | 3 | 20179710 | ||
| Pubmed | Induction and genetic regulation of mouse hepatic cytochrome P450 by cannabidiol. | 1.53e-06 | 6 | 149 | 3 | 8043019 | |
| Pubmed | New microsatellite size variants as markers for a cross-over hotspot in the C4-H-2D region. | 1.53e-06 | 6 | 149 | 3 | 8199408 | |
| Pubmed | RING finger protein RNF207, a novel regulator of cardiac excitation. | 1.53e-06 | 6 | 149 | 3 | 25281747 | |
| Pubmed | Three Hsp70 genes are located in the C4-H-2D region: possible candidates for the Orch-1 locus. | 1.53e-06 | 6 | 149 | 3 | 8449501 | |
| Interaction | CRK interactions | MPDZ KRT73 SERPINB6 PIK3CB KCNJ3 HSPA1A HSPA1B HSPA1L LCOR C1orf94 HSPA6 HSPA9 PRRC2B | 2.63e-06 | 370 | 144 | 13 | int:CRK |
| Interaction | CYP2C19 interactions | 3.54e-06 | 5 | 144 | 3 | int:CYP2C19 | |
| Interaction | CT45A2 interactions | 1.95e-05 | 8 | 144 | 3 | int:CT45A2 | |
| Interaction | LRRN2 interactions | 2.81e-05 | 25 | 144 | 4 | int:LRRN2 | |
| Interaction | CCNI2 interactions | 2.91e-05 | 9 | 144 | 3 | int:CCNI2 | |
| Interaction | CCDC117 interactions | 3.31e-05 | 26 | 144 | 4 | int:CCDC117 | |
| Interaction | CYP2C18 interactions | 3.86e-05 | 27 | 144 | 4 | int:CYP2C18 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXq26 | CT45A6 CT45A1 CT45A10 CT45A2 CT45A7 CT45A9 CT45A8 CT45A3 CT45A5 | 5.57e-09 | 171 | 149 | 9 | chrXq26 |
| Cytoband | Xq26.3 | 2.76e-06 | 67 | 149 | 5 | Xq26.3 | |
| Cytoband | 10q24 | 5.16e-06 | 35 | 149 | 4 | 10q24 | |
| GeneFamily | Heat shock 70kDa proteins | 1.44e-08 | 17 | 88 | 5 | 583 | |
| GeneFamily | Cytochrome P450 family 2 | 1.62e-08 | 35 | 88 | 6 | 1001 | |
| GeneFamily | WD repeat domain containing|Caspase recruitment domain containing|Apoptosome | 4.11e-04 | 30 | 88 | 3 | 959 | |
| GeneFamily | Acyl-CoA dehydrogenase family | 1.25e-03 | 11 | 88 | 2 | 974 | |
| GeneFamily | Dyneins, axonemal | 3.04e-03 | 17 | 88 | 2 | 536 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 3.41e-03 | 18 | 88 | 2 | 91 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_1_CELL | CT45A6 CT45A1 CT45A10 CT45A2 CT45A7 CT45A9 CT45A8 SLFN12L CT45A3 CT45A5 | 6.63e-12 | 69 | 149 | 10 | M45681 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_2_CELL | CT45A6 CT45A1 CT45A10 CT45A2 CT45A7 CT45A9 CT45A8 CT45A3 CT45A5 | 8.44e-09 | 104 | 149 | 9 | M45682 |
| Coexpression | SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN | 4.53e-06 | 20 | 149 | 4 | MM1104 | |
| Coexpression | DEN_INTERACT_WITH_LCA5 | 1.36e-05 | 26 | 149 | 4 | M1380 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_DN | CYP2B6 CYP2C19 CYP2C8 CYP2C18 ETS2 GCDH TENM1 ABCB11 ARHGEF26 | 2.33e-05 | 267 | 149 | 9 | M13449 |
| Coexpression | WENG_POR_DOSAGE | 2.45e-05 | 30 | 149 | 4 | MM1199 | |
| Coexpression | NOJIMA_SFRP2_TARGETS_UP | 3.19e-05 | 32 | 149 | 4 | M14772 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | CT45A6 CT45A1 CT45A10 CT45A2 MPDZ CT45A9 SLFN12L CT45A5 CDK11B | 5.93e-09 | 170 | 148 | 9 | fefb07a7e308b620f946b9ff2b01e1796446fe38 |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Myofibro_1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.48e-07 | 190 | 148 | 8 | 71a00f63fdd4eb4cc6f190d37e7a0417cdaafacb | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-Tnaive/CM_CD4_activated|lymph-node_spleen / Manually curated celltypes from each tissue | 3.14e-07 | 196 | 148 | 8 | c945dc6c56c61732e065daaad7e6f48c02ee183c | |
| ToppCell | PND01-Epithelial-Epithelial_Airway|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.35e-06 | 189 | 148 | 7 | 38cde34295566a4ecaf7d0a81c5a192cf17d0459 | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 3.47e-06 | 190 | 148 | 7 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 3.47e-06 | 190 | 148 | 7 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.85e-06 | 193 | 148 | 7 | 2f203f6f0c2135acb046c9351a633c3b5b254a46 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.40e-06 | 197 | 148 | 7 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-05 | 149 | 148 | 6 | a6406c4c9404271a2f4c615c6cd3265b2d759b12 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.44e-05 | 157 | 148 | 6 | b9d04ee417c0d8ea0801d10f1c54e138587009fd | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-05 | 160 | 148 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-05 | 160 | 148 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.72e-05 | 162 | 148 | 6 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.90e-05 | 165 | 148 | 6 | 3c8baed838eccb6e720bacb7458f087647dc1222 | |
| ToppCell | Ciliated_cells-A-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.74e-05 | 176 | 148 | 6 | 1c364155f46b9a7c995bdc2cc2333c437cd90f5b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.74e-05 | 176 | 148 | 6 | cb21342dd135cc80a50aafe7bf8bf31265db68dd | |
| ToppCell | Adult-Immune-enucleated_erythrocyte-D231|Adult / Lineage, Cell type, age group and donor | 2.83e-05 | 177 | 148 | 6 | 15ee303fb6caea1fd645c3b777666196ce500a1c | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-05 | 178 | 148 | 6 | b1db59344c074c7c80169fc2c5cd5fc89f3fe463 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-05 | 178 | 148 | 6 | 579cdc14f28b459e200ae2102e0bd4df8a2c0dcb | |
| ToppCell | Ciliated_cells-A-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.01e-05 | 179 | 148 | 6 | 0e6c22de2e3fb0ff23b3301863cf4011c5c59dff | |
| ToppCell | Ciliated_cells-B-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 3.11e-05 | 180 | 148 | 6 | bdea5ec6b60fc8c7cce4d71db5da74ac8675e211 | |
| ToppCell | facs-GAT-Fat-3m-Lymphocytic-T_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-05 | 182 | 148 | 6 | 751bd3e3b49de961523e98197688a05c998c121a | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-05 | 182 | 148 | 6 | c4a7007c864a9455a7e7447e28ccd380878a6a0f | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-05 | 182 | 148 | 6 | c315d820ffad912c014ba5eac6f5fa6de1a94384 | |
| ToppCell | cellseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.30e-05 | 182 | 148 | 6 | deb53a4f84e4cd5c3b4180a4ac43249da9d738f7 | |
| ToppCell | Ciliated_cells-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 3.30e-05 | 182 | 148 | 6 | e93968f800bfeb258e4e834fc8bf92d1cb72cd73 | |
| ToppCell | facs-Thymus-Epithelium-3m-Lymphocytic-DN_to_DP_transition_(most_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.34e-05 | 110 | 148 | 5 | 3a641dced828ed97a8eea70d0a7b76f33630c9be | |
| ToppCell | droplet-Lung-LUNG-30m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-05 | 183 | 148 | 6 | 3991830726d05cf19606d540de04093985b7bdeb | |
| ToppCell | droplet-Lung-LUNG-30m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-05 | 183 | 148 | 6 | cc844f54c7564bf432b179ca63bc7c4b9b8cfdd9 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.51e-05 | 184 | 148 | 6 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.62e-05 | 185 | 148 | 6 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.62e-05 | 185 | 148 | 6 | 3e39a3cb534dfe2301930f3e2f7e8cefb522c158 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 3.62e-05 | 185 | 148 | 6 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.73e-05 | 186 | 148 | 6 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | 10x5'-lymph-node_spleen-Hematopoietic_progenitors-Progenitor_pre-Lymphocytic-T|lymph-node_spleen / Manually curated celltypes from each tissue | 3.73e-05 | 186 | 148 | 6 | 17eec1efad1f5e9ced1eb6bc9eb5dd7ded789c61 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-05 | 187 | 148 | 6 | 04dba2ed09ee4180830bdf0191921696697ea234 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.84e-05 | 187 | 148 | 6 | 9e10ed56090d82589bc457788282f664b70ace4b | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-05 | 187 | 148 | 6 | 805dafe22f835ece4dd091d8030d0a63b52a48dd | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 3.96e-05 | 188 | 148 | 6 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 3.96e-05 | 188 | 148 | 6 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 3.96e-05 | 188 | 148 | 6 | 0758b474457efa36488e0195f7357100f4b6a090 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.96e-05 | 188 | 148 | 6 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.96e-05 | 188 | 148 | 6 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.08e-05 | 189 | 148 | 6 | 057d7a03fdbe779122b203619a6f947f49b84d28 | |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.08e-05 | 189 | 148 | 6 | a2da5debd10f27b1280b40141ef0bfef007cc72c | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.08e-05 | 189 | 148 | 6 | 68a3cf7763d6f9b95d6d6524eff7a16042703f1d | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 4.08e-05 | 189 | 148 | 6 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.08e-05 | 189 | 148 | 6 | 9f57a131902d23494bf389baf6e6e2d99f88b2c8 | |
| ToppCell | droplet-Lung-18m-Epithelial-airway_epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.08e-05 | 189 | 148 | 6 | fe958fdf9963c2dfe270f67f0da36b3264d0017c | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 4.08e-05 | 189 | 148 | 6 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 4.08e-05 | 189 | 148 | 6 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 4.08e-05 | 189 | 148 | 6 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.08e-05 | 189 | 148 | 6 | e443b02502edaefa94567a9e8af5756e8e11ff30 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_1|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.20e-05 | 190 | 148 | 6 | d24af6af3271e34afab744352afd28be8a7cc5c3 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 4.20e-05 | 190 | 148 | 6 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | Ciliated_cells-A|World / lung cells shred on cell class, cell subclass, sample id | 4.20e-05 | 190 | 148 | 6 | cd87731aaa7d252424f79cfce9f7931457f17bdf | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-GHRL+_neuroendocrine|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.20e-05 | 190 | 148 | 6 | b5c6f3248c0c2f648e1578457c6a729ca22bf0da | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 4.32e-05 | 191 | 148 | 6 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 4.32e-05 | 191 | 148 | 6 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.32e-05 | 191 | 148 | 6 | 1e21de183a9c09cfb6aad3f9b948087fb6bad061 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.32e-05 | 191 | 148 | 6 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.32e-05 | 191 | 148 | 6 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.32e-05 | 191 | 148 | 6 | 96483adb97c81208aa513782550acd8a08b63866 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.32e-05 | 191 | 148 | 6 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 4.45e-05 | 192 | 148 | 6 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | IPF-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 4.45e-05 | 192 | 148 | 6 | d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11 | |
| ToppCell | COPD-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 4.45e-05 | 192 | 148 | 6 | eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 4.45e-05 | 192 | 148 | 6 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 4.58e-05 | 193 | 148 | 6 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 4.58e-05 | 193 | 148 | 6 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | 3'-Distal_airway|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.72e-05 | 194 | 148 | 6 | e9ff4398e880d13894e52c0ba9cf19a7662c248b | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 4.72e-05 | 194 | 148 | 6 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | cellseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.85e-05 | 195 | 148 | 6 | d8bf15aa7cdbc5f29b58e1e6cff76c257f0ea12e | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 4.85e-05 | 195 | 148 | 6 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | cellseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.85e-05 | 195 | 148 | 6 | e7f069f557a59ee7b502ff82ad4c9f47fa619ba8 | |
| ToppCell | 3'-Distal_airway-Epithelial|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.85e-05 | 195 | 148 | 6 | 72fa2ba064055e2fee2b2cb8633c8f9a3c4373da | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.99e-05 | 196 | 148 | 6 | a37ba02446eef5d1fab703204583f6550a8ec3e1 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|Epithelial / Condition, Lineage and Cell class | 4.99e-05 | 196 | 148 | 6 | de7aa31354b019d7321a8ef965d59ce2e8b89276 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.99e-05 | 196 | 148 | 6 | a156840330630e518bc85633dded6f2c3ead3b30 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.99e-05 | 196 | 148 | 6 | 009e83c7251cf300be78b263634d233a8d972a68 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.99e-05 | 196 | 148 | 6 | 89ea4d2086e1c769c5a87f1471a6cd4acabcfe33 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.14e-05 | 197 | 148 | 6 | 71fea4aa6ce96c7693fa94792d08770622873850 | |
| ToppCell | control-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.14e-05 | 197 | 148 | 6 | e453d085182364ca347cbcc9dc995c62c3353016 | |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.14e-05 | 197 | 148 | 6 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.28e-05 | 198 | 148 | 6 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | Caecum-T_cell-Th1|T_cell / Region, Cell class and subclass | 5.43e-05 | 199 | 148 | 6 | 13a80e6d3cf9c831edbe0644545071153e35f82b | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T9|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.43e-05 | 199 | 148 | 6 | e9c83555d2197b740797a9f33b64f8f7a7ba1ee2 | |
| ToppCell | (09)_Interm._secr.>cil.|World / shred by cell type by condition | 5.58e-05 | 200 | 148 | 6 | 3305e14dba12e94da42f0414fdc7a2c8caf0a183 | |
| ToppCell | (05)_Ciliated-(2)_48hpi|(05)_Ciliated / shred by cell type and Timepoint | 5.92e-05 | 124 | 148 | 5 | fc8cce8c1809edafbc4e69e501dd4f016f5dfc0b | |
| ToppCell | facs-Thymus-Epithelium-3m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.15e-05 | 125 | 148 | 5 | 6bdbbd47b699d836900bd055f2144cf960b5e7b6 | |
| ToppCell | facs-Thymus-Epithelium-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.96e-05 | 132 | 148 | 5 | 6f711fe84135406a8114a898a14c5ea0dfad74f2 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Pitx2_(Subthalamic_nucleus_(STN))-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 8.23e-05 | 69 | 148 | 4 | 10d5fccc1fa10ffc9051df42dd0e5046d97ec4af | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 8.23e-05 | 69 | 148 | 4 | 4831573a45ace5f06cd409f0e75bce838ed65a88 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Pitx2_(Subthalamic_nucleus_(STN))|Thalamus / BrainAtlas - Mouse McCarroll V32 | 8.23e-05 | 69 | 148 | 4 | 9d7e911434c6b18327fa7adaec5c449e0c300919 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Papillary_Muscle_Invasive_Urothelial_Carcinoma-8|TCGA-Bladder / Sample_Type by Project: Shred V9 | 1.41e-04 | 149 | 148 | 5 | 89705865e94360c1288ee98c5a6b381f3c6242b3 | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte-pericyte_B|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.50e-04 | 151 | 148 | 5 | 8ba15ab24fe2e71df0a2a7511ca451ad2376bd91 | |
| ToppCell | 18-Airway-Epithelial-Goblet-like_secretory|Airway / Age, Tissue, Lineage and Cell class | 1.59e-04 | 153 | 148 | 5 | 14a60220e169ce642771636de982a7b02e5b2608 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.64e-04 | 154 | 148 | 5 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.64e-04 | 154 | 148 | 5 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.74e-04 | 156 | 148 | 5 | 8349604bd801e20d33770f7d8243598c3756302b | |
| Computational | Cytochrome P450. | 4.07e-08 | 14 | 81 | 5 | MODULE_106 | |
| Computational | Genes in the cancer module 135. | 3.36e-05 | 25 | 81 | 4 | MODULE_135 | |
| Drug | 4',5-dihydroxydiclofenac | 5.63e-11 | 6 | 144 | 5 | CID003052567 | |
| Drug | 3'-hydroxydiclofenac | 5.63e-11 | 6 | 144 | 5 | CID000112230 | |
| Drug | 5-hydroxydiclofenac | 7.21e-09 | 12 | 144 | 5 | CID003052566 | |
| Drug | 1,4-naphthoquinone | 1.20e-08 | 26 | 144 | 6 | ctd:C035342 | |
| Drug | 2'-(glutathion-S-yl)-deschlorodiclofenac | 2.69e-08 | 15 | 144 | 5 | ctd:C586542 | |
| Drug | BP-7,8-oxide | 4.56e-08 | 32 | 144 | 6 | CID000037455 | |
| Drug | 5-fluorotryptamine | 5.29e-08 | 7 | 144 | 4 | ctd:C034536 | |
| Drug | 1,2-dihydroxynaphthalene | 7.10e-08 | 57 | 144 | 7 | CID000011318 | |
| Drug | Azamulinum | 7.57e-08 | 18 | 144 | 5 | CID003086060 | |
| Drug | D 703 | 7.57e-08 | 18 | 144 | 5 | CID000054088 | |
| Drug | hydroxytolbutamide | 1.02e-07 | 19 | 144 | 5 | CID000003656 | |
| Drug | 5-bromotryptamine | 1.05e-07 | 8 | 144 | 4 | ctd:C040997 | |
| Drug | 3C etc | 1.36e-07 | 20 | 144 | 5 | CID000164045 | |
| Drug | 4,5-dihydropyrazole-1,5-dicarboxylic acid 1-((4-chlorophenyl)-amide) 5-(2-oxo-2H-(1,3')bipyridinyl-6'-yl)-amide | 1.89e-07 | 9 | 144 | 4 | ctd:C545880 | |
| Drug | Tryptamines | 1.89e-07 | 9 | 144 | 4 | ctd:D014363 | |
| Drug | 5-chlorotryptamine | 1.89e-07 | 9 | 144 | 4 | ctd:C529169 | |
| Drug | 5-(N-(4-((4-ethylbenzyl)thio)phenyl)sulfamoyl)-2-methylbenzoic acid | 1.89e-07 | 9 | 144 | 4 | ctd:C000588958 | |
| Drug | norketobemidone | 3.13e-07 | 10 | 144 | 4 | CID000161154 | |
| Drug | sitaxsentan | 3.13e-07 | 10 | 144 | 4 | ctd:C106276 | |
| Drug | Ticlopidine | 4.53e-07 | 25 | 144 | 5 | ctd:D013988 | |
| Drug | Sulfinpyrazone | 4.89e-07 | 11 | 144 | 4 | ctd:D013442 | |
| Drug | trans-1,2-dihydro-1,2-naphthalenediol | 4.89e-07 | 11 | 144 | 4 | ctd:C507866 | |
| Drug | 2cgu | 5.68e-07 | 48 | 144 | 6 | CID003506204 | |
| Drug | 19-HETE | 6.44e-07 | 49 | 144 | 6 | CID006439528 | |
| Drug | BP-9,10-oxide | 6.81e-07 | 27 | 144 | 5 | CID000037456 | |
| Drug | Brn 4136738 | 6.81e-07 | 27 | 144 | 5 | CID000050331 | |
| Drug | C14845 | 6.81e-07 | 27 | 144 | 5 | CID011954064 | |
| Drug | Sertraline | 7.04e-07 | 115 | 144 | 8 | ctd:D020280 | |
| Drug | 6-hydroxymelatonin | 7.28e-07 | 50 | 144 | 6 | CID000001864 | |
| Drug | carveol | 7.30e-07 | 12 | 144 | 4 | CID000007438 | |
| Drug | 9-OH-BaP-4,5-oxide | 8.25e-07 | 28 | 144 | 5 | CID000115064 | |
| Drug | 7-hydroxyquinoline | 1.05e-06 | 13 | 144 | 4 | CID000011378 | |
| Drug | triazolam | 1.16e-06 | 54 | 144 | 6 | CID000005556 | |
| Drug | 19-hydroxytestosterone | 1.18e-06 | 30 | 144 | 5 | CID000150968 | |
| Drug | 11-H-14,15-EETA | 1.18e-06 | 30 | 144 | 5 | CID011954058 | |
| Drug | 1,1-dichloroethylene | 2.18e-06 | 60 | 144 | 6 | CID000006366 | |
| Drug | 12(13)-EpOME | 2.27e-06 | 34 | 144 | 5 | CID000001416 | |
| Drug | TCEO | 2.27e-06 | 34 | 144 | 5 | CID000028167 | |
| Drug | AC1O5XSP | 2.27e-06 | 34 | 144 | 5 | CID006442739 | |
| Drug | DEDTC | 2.27e-06 | 34 | 144 | 5 | CID000032064 | |
| Drug | BP-4,5-oxide | 2.40e-06 | 61 | 144 | 6 | CID000037786 | |
| Drug | bufuralol | 2.45e-06 | 5 | 144 | 3 | ctd:C010831 | |
| Drug | 2-oxo-clopidogrel | 2.45e-06 | 5 | 144 | 3 | ctd:C540904 | |
| Drug | benfuracarb | 2.45e-06 | 5 | 144 | 3 | ctd:C096128 | |
| Drug | AC1L1CJI | 2.63e-06 | 35 | 144 | 5 | CID000001929 | |
| Drug | 1-phenylazo-2-naphthol | 2.63e-06 | 16 | 144 | 4 | ctd:C024336 | |
| Drug | 1,1,1-trichloro-2-(4-hydroxyphenyl)-2-(4-methoxyphenyl)ethane | 2.63e-06 | 16 | 144 | 4 | ctd:C495657 | |
| Drug | chlorzoxazone | 2.91e-06 | 63 | 144 | 6 | CID000002733 | |
| Drug | 15-H-11,12-EETA | 3.04e-06 | 36 | 144 | 5 | CID011954042 | |
| Drug | AC1L3NGJ | 3.04e-06 | 36 | 144 | 5 | CID000092121 | |
| Drug | piperonyl butoxide | 4.19e-06 | 67 | 144 | 6 | CID000005794 | |
| Drug | propoxyphene | 4.19e-06 | 67 | 144 | 6 | CID000010100 | |
| Drug | 7-benzyloxyquinoline | 4.38e-06 | 18 | 144 | 4 | CID003035604 | |
| Drug | styrene glycol | 4.38e-06 | 18 | 144 | 4 | CID000007149 | |
| Drug | pleuromutilin | 4.38e-06 | 18 | 144 | 4 | CID000031326 | |
| Drug | 2,4-oxazolidinedione | 4.38e-06 | 18 | 144 | 4 | CID000097389 | |
| Drug | 5,6-epoxyeicosatrienoic acid | 4.57e-06 | 68 | 144 | 6 | CID000001778 | |
| Drug | 11,14,15-THET | 4.57e-06 | 39 | 144 | 5 | CID006439531 | |
| Drug | 4,4'-cyclohexylidenebisphenol | 4.89e-06 | 6 | 144 | 3 | ctd:C570106 | |
| Drug | mono-OH | 4.89e-06 | 6 | 144 | 3 | CID000183679 | |
| Drug | avasimibe | 4.89e-06 | 6 | 144 | 3 | ctd:C423185 | |
| Drug | AC1O5Z5L | 4.89e-06 | 6 | 144 | 3 | CID006443527 | |
| Drug | mepirodipine | 4.89e-06 | 6 | 144 | 3 | ctd:C050699 | |
| Drug | 8(9)-EET | 4.98e-06 | 69 | 144 | 6 | CID000001901 | |
| Drug | 1h1q | 5.42e-06 | 70 | 144 | 6 | CID000001540 | |
| Drug | D 617 | 5.52e-06 | 19 | 144 | 4 | CID000093168 | |
| Drug | 1-aminobenzotriazole | 5.89e-06 | 71 | 144 | 6 | CID000001367 | |
| Drug | furafylline | 5.89e-06 | 41 | 144 | 5 | CID000003433 | |
| Drug | carteolol | 6.39e-06 | 72 | 144 | 6 | CID000002583 | |
| Drug | 11,12,15-trihydroxyeicosatrienoic acid | 6.65e-06 | 42 | 144 | 5 | CID006439610 | |
| Drug | 3-methoxymorphinan | 6.87e-06 | 20 | 144 | 4 | CID000001671 | |
| Drug | sulfaphenazole | 8.40e-06 | 44 | 144 | 5 | CID000005335 | |
| Drug | polybrominated biphenyl | 8.40e-06 | 44 | 144 | 5 | CID000042948 | |
| Drug | nirvanol | 8.45e-06 | 21 | 144 | 4 | CID000091480 | |
| Drug | zafirlukast | 8.45e-06 | 21 | 144 | 4 | ctd:C062735 | |
| Drug | 16-O-demethylaconitine | 8.51e-06 | 7 | 144 | 3 | ctd:C486136 | |
| Drug | trichloroacetyl chloride | 8.51e-06 | 7 | 144 | 3 | CID000006420 | |
| Drug | 5-hydroxydiclofenac | 8.51e-06 | 7 | 144 | 3 | ctd:C117715 | |
| Drug | 6-Fluoro-6-desoxyoxymorphone | 8.51e-06 | 7 | 144 | 3 | CID005486899 | |
| Drug | naphthalene-1,2-dihydrodiol | 9.41e-06 | 45 | 144 | 5 | CID000000362 | |
| Drug | AC1Q7AUJ | 9.71e-06 | 117 | 144 | 7 | CID000003303 | |
| Drug | C20H32O4 | 1.02e-05 | 78 | 144 | 6 | CID000001440 | |
| Drug | BP-7,8-diol | 1.02e-05 | 78 | 144 | 6 | CID000025892 | |
| Drug | C14802 | 1.17e-05 | 47 | 144 | 5 | CID011954053 | |
| Drug | trimipramine | 1.18e-05 | 80 | 144 | 6 | CID000005584 | |
| Drug | 3-hydroxymethylantipyrine | 1.24e-05 | 23 | 144 | 4 | CID000123963 | |
| Drug | 4-hydroxy-2-nonenal | CYP2B6 ZBTB7C ETS2 PGM2L1 REV3L PXK SPAG5 STAT6 TXNRD1 ZMAT3 PIK3CB HSPA1A HSPA1B HSPA1L HSPA9 TOP2A RAD54L | 1.24e-05 | 798 | 144 | 17 | ctd:C027576 |
| Drug | nitro-L | 1.30e-05 | 48 | 144 | 5 | CID000006849 | |
| Drug | C14800 | 1.30e-05 | 48 | 144 | 5 | CID011954051 | |
| Drug | naphthalene | 1.35e-05 | 123 | 144 | 7 | CID000000931 | |
| Drug | 13-hydroxyeicosatetraenoic acid | 1.36e-05 | 8 | 144 | 3 | CID006439499 | |
| Drug | 5-fluoro-alpha-methyltryptamine | 1.36e-05 | 8 | 144 | 3 | ctd:C051101 | |
| Drug | 5-methyltryptamine | 1.36e-05 | 8 | 144 | 3 | ctd:C027552 | |
| Drug | 11-HODE | 1.36e-05 | 8 | 144 | 3 | CID006438497 | |
| Drug | AC1MI0E8 | 1.36e-05 | 8 | 144 | 3 | CID003036008 | |
| Drug | 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid | 1.36e-05 | 8 | 144 | 3 | ctd:C585955 | |
| Drug | clobazam | 1.36e-05 | 8 | 144 | 3 | ctd:C012255 | |
| Drug | germacrone | 1.36e-05 | 8 | 144 | 3 | ctd:C048393 | |
| Drug | 7-methyltryptamine | 1.36e-05 | 8 | 144 | 3 | ctd:C036696 | |
| Drug | bromobenzene-3,4-oxide | 1.44e-05 | 49 | 144 | 5 | CID000108121 | |
| Disease | X-21258 measurement | 9.16e-08 | 3 | 134 | 3 | EFO_0800802 | |
| Disease | major depressive disorder (is_implicated_in) | 9.24e-07 | 17 | 134 | 4 | DOID:1470 (is_implicated_in) | |
| Disease | Major depression, single episode | 7.54e-06 | 9 | 134 | 3 | C0024517 | |
| Disease | clopidogrel metabolite measurement | 1.50e-05 | 33 | 134 | 4 | EFO_0007966 | |
| Disease | Major Depressive Disorder | 1.61e-05 | 243 | 134 | 8 | C1269683 | |
| Disease | autosomal recessive nonsyndromic deafness 16 (implicated_via_orthology) | 2.05e-05 | 2 | 134 | 2 | DOID:0110471 (implicated_via_orthology) | |
| Disease | PIK3CA/PIK3R1 measurement | 2.05e-05 | 2 | 134 | 2 | EFO_0021971 | |
| Disease | X-14473 measurement | 2.05e-05 | 2 | 134 | 2 | EFO_0021370 | |
| Disease | Unipolar Depression | 2.54e-05 | 259 | 134 | 8 | C0041696 | |
| Disease | cyclo(leu-pro) measurement | 6.12e-05 | 3 | 134 | 2 | EFO_0800676 | |
| Disease | Hermansky-Pudlak syndrome 1 (implicated_via_orthology) | 6.12e-05 | 3 | 134 | 2 | DOID:0060539 (implicated_via_orthology) | |
| Disease | eosinophilic esophagitis (is_implicated_in) | 2.03e-04 | 5 | 134 | 2 | DOID:13922 (is_implicated_in) | |
| Disease | graft-versus-host disease (biomarker_via_orthology) | 2.03e-04 | 5 | 134 | 2 | DOID:0081267 (biomarker_via_orthology) | |
| Disease | Cardiomyopathies | 3.26e-04 | 130 | 134 | 5 | C0878544 | |
| Disease | glycine conjugate of C10H14O2 (1) measurement | 4.24e-04 | 7 | 134 | 2 | EFO_0800655 | |
| Disease | Drug Allergy | 5.39e-04 | 35 | 134 | 3 | C0013182 | |
| Disease | S-6-hydroxywarfarin to S-warfarin ratio measurement | 7.06e-04 | 88 | 134 | 4 | EFO_0803332 | |
| Disease | plasma clozapine-to-N-desmethylclozapine ratio measurement | 7.22e-04 | 9 | 134 | 2 | EFO_0600040 | |
| Disease | Neurodevelopmental Disorders | 8.69e-04 | 93 | 134 | 4 | C1535926 | |
| Disease | Hermanski-Pudlak Syndrome | 8.99e-04 | 10 | 134 | 2 | C0079504 | |
| Disease | Hermansky-Pudlak syndrome | 8.99e-04 | 10 | 134 | 2 | cv:C0079504 | |
| Disease | eosinophilic esophagitis | 9.10e-04 | 163 | 134 | 5 | EFO_0004232 | |
| Disease | primary immunodeficiency disease (is_implicated_in) | 9.24e-04 | 42 | 134 | 3 | DOID:612 (is_implicated_in) | |
| Disease | S-warfarin to R-warfarin ratio measurement | 9.40e-04 | 95 | 134 | 4 | EFO_0803331 | |
| Disease | X-11308 measurement | 1.10e-03 | 11 | 134 | 2 | EFO_0800693 | |
| Disease | Paranoia | 1.10e-03 | 11 | 134 | 2 | C1456784 | |
| Disease | thymol sulfate measurement | 1.31e-03 | 12 | 134 | 2 | EFO_0021170 | |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 1.31e-03 | 12 | 134 | 2 | DOID:9119 (implicated_via_orthology) | |
| Disease | Kawasaki disease (is_implicated_in) | 1.31e-03 | 12 | 134 | 2 | DOID:13378 (is_implicated_in) | |
| Disease | ghrelin measurement | 1.45e-03 | 49 | 134 | 3 | EFO_0600001 | |
| Disease | L2 Acute Lymphoblastic Leukemia | 1.54e-03 | 50 | 134 | 3 | C0023453 | |
| Disease | depressive disorder (biomarker_via_orthology) | 1.72e-03 | 52 | 134 | 3 | DOID:1596 (biomarker_via_orthology) | |
| Disease | Childhood Acute Lymphoblastic Leukemia | 1.72e-03 | 52 | 134 | 3 | C0023452 | |
| Disease | Left ventricular noncompaction | 1.80e-03 | 14 | 134 | 2 | C1960469 | |
| Disease | ecosanoids measurement | 2.02e-03 | 55 | 134 | 3 | EFO_0020044 | |
| Disease | platelet storage pool deficiency (implicated_via_orthology) | 2.07e-03 | 15 | 134 | 2 | DOID:2223 (implicated_via_orthology) | |
| Disease | 16a-hydroxy DHEA 3-sulfate measurement | 2.07e-03 | 15 | 134 | 2 | EFO_0800301 | |
| Disease | gliosarcoma | 2.36e-03 | 16 | 134 | 2 | C0206726 | |
| Disease | Cannabis use | 2.36e-03 | 16 | 134 | 2 | EFO_0007585 | |
| Disease | andro steroid monosulfate C19H28O6S (1) measurement | 2.36e-03 | 16 | 134 | 2 | EFO_0800305 | |
| Disease | Schizophrenia | PSD3 BACE1 PIK3CB KCNJ3 KMT2A NLGN2 HSPA1A HSPA1B HSPA1L MED12 HSPA9 | 2.37e-03 | 883 | 134 | 11 | C0036341 |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 2.66e-03 | 17 | 134 | 2 | EFO_0004611, EFO_0007800 | |
| Disease | non-Hodgkin lymphoma (is_implicated_in) | 2.66e-03 | 17 | 134 | 2 | DOID:0060060 (is_implicated_in) | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 2.72e-03 | 61 | 134 | 3 | C1961102 | |
| Disease | Adrenocortical carcinoma | 2.99e-03 | 18 | 134 | 2 | C0206686 | |
| Disease | telomere length | 3.14e-03 | 313 | 134 | 6 | EFO_0004505 | |
| Disease | Breast Carcinoma | 3.26e-03 | 538 | 134 | 8 | C0678222 | |
| Disease | metabolonic lactone sulfate measurement | 3.33e-03 | 19 | 134 | 2 | EFO_0800659 | |
| Disease | cystathionine measurement | 3.33e-03 | 19 | 134 | 2 | EFO_0010474 | |
| Disease | Hemorrhage | 3.69e-03 | 20 | 134 | 2 | C0019080 | |
| Disease | Cardiomyopathies, Primary | 3.86e-03 | 69 | 134 | 3 | C0033141 | |
| Disease | Myocardial Diseases, Secondary | 3.86e-03 | 69 | 134 | 3 | C0036529 | |
| Disease | Nonorganic psychosis | 3.86e-03 | 69 | 134 | 3 | C0349204 | |
| Disease | Precursor B-cell lymphoblastic leukemia | 4.06e-03 | 21 | 134 | 2 | C1292769 | |
| Disease | Primary familial hypertrophic cardiomyopathy | 4.46e-03 | 22 | 134 | 2 | cv:C0949658 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MDRFLVKGAQGGLLR | 1 | Q6NS38 | |
| RRGSFVEMVDNLRGK | 56 | P56817 | |
| GNLLQMDRRGLLKSF | 41 | P20813 | |
| NIEEDFRNGLKLMLL | 61 | P35609 | |
| LMLSSNRERFLKGEG | 321 | Q8WYA6 | |
| NRERFLKGEGLQLMN | 326 | Q8WYA6 | |
| KQRRDFLGEASIMGQ | 716 | P54756 | |
| LRNFGMGKRSIEDRV | 131 | P10632 | |
| QRMALLARKQGAGDS | 31 | P0DMU8 | |
| IEREFRIMKALANAG | 326 | Q6JQN1 | |
| LRKFGFRAMLGQDIA | 831 | O95342 | |
| KNVERMGRLLGLETN | 856 | Q96DR7 | |
| KRFGALLSDQGFDLM | 686 | P21127 | |
| GFQKERRRMASGNGL | 16 | Q6P1W5 | |
| MNNKFGLQRILGDER | 241 | O60879 | |
| DLNTGRMRRKAIFGD | 421 | Q14692 | |
| KGAALMRNRDLQLEI | 196 | Q9H257 | |
| QRMALLARKQGAGDS | 31 | P0DMV0 | |
| RLVMAAANRLRKEGG | 436 | P55084 | |
| GLKSEFRQNLGRMFI | 726 | O94973 | |
| DRMFDKNLQDLVRGI | 11 | O14617 | |
| RFQLMAKLAEGAGIQ | 366 | Q86U06 | |
| LKQGSRLMDNFLIRE | 126 | Q9NS91 | |
| IDQKLEGFMNQRGAR | 251 | Q92698 | |
| ILRNFGMGKRSIEER | 131 | P24903 | |
| GRDFLRKQMRGDLFT | 216 | Q02548 | |
| GFGDRLFLKQRMSLL | 376 | Q96NW4 | |
| EKGLYRRGEAQLLMN | 351 | Q13451 | |
| GAAFKDGRLRMNDQL | 536 | Q8TEW8 | |
| NRAKMAEGLALALAR | 116 | Q92805 | |
| GALQQAKEELARMLR | 401 | Q86Y46 | |
| ERLLLMQEAKGRGSA | 261 | Q9HB89 | |
| EDMNGAFSGLDKLRR | 376 | Q6UXM1 | |
| QRMALLARKQGAGDS | 31 | P0DMU9 | |
| GGDLMFQIQRSRKFD | 491 | Q02156 | |
| IGGNKVDAILDMNFR | 196 | O75325 | |
| HFLLQRKGLSRQMIG | 561 | Q6DN90 | |
| RKGLSRQMIGEFLGN | 566 | Q6DN90 | |
| FILERKGLSRQMIGE | 791 | Q5JU85 | |
| KGLSRQMIGEFLGNR | 796 | Q5JU85 | |
| LEKRERENGSNLAFM | 926 | Q5JUK3 | |
| EGMLIQLRFLKRQDL | 216 | Q96A33 | |
| ERAMTKDNNLLGRFE | 446 | P0DMV9 | |
| EKGKQRNRRIFGLLM | 136 | Q9H307 | |
| RNRRIFGLLMGTLQK | 141 | Q9H307 | |
| EFNLSRMKFRGNGAL | 201 | Q96JN0 | |
| ENLLRNGMNKELRDR | 46 | Q6PCE3 | |
| GDLMKRINRQRGVLF | 86 | Q6P3R8 | |
| QRMALLARKQGAGDS | 31 | Q8NHU0 | |
| GQMLCNLGKERFLEL | 136 | P15036 | |
| MLFGGEDRELIQRRK | 406 | Q1MSJ5 | |
| MDFRGLGRIFKGLAQ | 1876 | Q96JB1 | |
| EGERAMTKDNNLLGR | 446 | P34931 | |
| MTKDNNLLGRFDLTG | 451 | P34931 | |
| EALKLRLNLVGGMFD | 1531 | Q93074 | |
| SLNILRAAMQGERKF | 621 | Q8TE49 | |
| RAAMQGERKFIFAGL | 626 | Q8TE49 | |
| GSQEERRKLQGNMLL | 56 | Q8TAM6 | |
| REMAGDNKLLGQFTL | 491 | P38646 | |
| LQRKGLSRQMIGEFL | 691 | Q9UPP2 | |
| RLRAMGKGNLEVNRN | 406 | O95800 | |
| LFANKVRNLMAEALG | 301 | Q7L5N7 | |
| DADQLRIGNDGIFML | 106 | Q9BT67 | |
| QRMALLARKQGAGDS | 31 | Q5HYN5 | |
| QRMALLARKQGAGDS | 31 | P0DMV2 | |
| KSGDRILFLNGLDMR | 316 | A4D2P6 | |
| GDRRKNMEGLQAALQ | 616 | Q9BX69 | |
| KARFLALQGDMEQAL | 621 | Q9Y6J0 | |
| IRVNLAMEGRAKGEL | 681 | Q9BXL6 | |
| LRNFGMGKRSIEDRV | 131 | P33261 | |
| IKGLGRVFRIMDDDN | 41 | Q8WWF8 | |
| GKALDIARQARDMLG | 376 | Q92947 | |
| QLRDKAGEMLQLQGR | 291 | H7BZ55 | |
| QRMALLARKQGAGDS | 31 | Q5DJT8 | |
| KLRRFNAGIMELGLV | 356 | P09172 | |
| GVVERNMRDKLFLTG | 451 | Q6UWU2 | |
| IMLFTRKEDLGAGNL | 561 | Q8ND71 | |
| ALLMFSGDRAQRLKI | 641 | Q6TDU7 | |
| GDMIAGKNLEDFLRN | 686 | Q8IY85 | |
| GNLRELALARMKDLG | 381 | Q9H9T3 | |
| QRMALLARKQGAGDS | 31 | P0DMV1 | |
| GKRGNTMAERRQLFA | 6 | Q9Y4J8 | |
| MLGSGFKAERLRVNL | 1 | P53990 | |
| LKQLSFAGVNGLRML | 3706 | Q03164 | |
| MGALFRLLLQERGKA | 1 | Q8TB33 | |
| LRNFGMGKRSIEDRV | 131 | P33260 | |
| EGERAMTKDNNLLGR | 446 | P17066 | |
| MTKDNNLLGRFELSG | 451 | P17066 | |
| ERAMTKDNNLLGRFE | 446 | P0DMV8 | |
| LRNFGMGKRSIEDRV | 131 | P11712 | |
| GDLRQRMDKFVKNRG | 426 | Q92902 | |
| DLMKLAERSGFGGNR | 3891 | Q8IVF4 | |
| RDNGEMRRKTLLALF | 441 | Q8NFZ4 | |
| LQLKRRGREMFEVTG | 111 | Q9BWS9 | |
| QRMALLARKQGAGDS | 31 | P0DMU7 | |
| AEKLMRLQNQRGGRI | 126 | Q8N4E7 | |
| QEQRRELKSAGGLMF | 16 | Q9UNQ2 | |
| MDQKLSGQRAALERG | 441 | Q86XP0 | |
| LRNKEVLGAMRRVFG | 291 | Q8N349 | |
| RKNLFAEMREQLGSA | 286 | Q6KF10 | |
| ARGGSQMDVLQRKLR | 1411 | P46939 | |
| LFGSMQDRLAERKAL | 246 | Q6ZRF8 | |
| MREFRGLLKDAQTQL | 606 | Q96R06 | |
| ANILRKLLFNEEAMG | 496 | Q8N4U5 | |
| AKDFRSRMEGVGQLL | 776 | Q6ZUX3 | |
| LARNVFAGMIRLKEL | 196 | Q86VH5 | |
| GELDMRKIGQARNTL | 236 | O94906 | |
| VKDLNFRMFDVGGQR | 191 | P19087 | |
| RAVLEMKDGRNSFIG | 136 | Q6ZW05 | |
| QERLRKGGATALMDA | 161 | Q05823 | |
| ELGGQRDLVQAMKRR | 481 | Q6ZNE9 | |
| LRNLGMTDAFELGKA | 286 | P35237 | |
| KMDEDGFLRQRGNDI | 2211 | Q9UKZ4 | |
| LDGAKMVARFFLQLG | 951 | Q8NEZ3 | |
| MLNGGRRIDYVLQEK | 941 | Q9Y6Y8 | |
| VLMKDVGNRIRADGR | 416 | A8MXQ7 | |
| GVIFKNGDDLRQDML | 801 | P42338 | |
| VTELMRKGNLQAFLG | 301 | Q9H3Y6 | |
| LAKEELNFLARLMGG | 291 | Q8WVF1 | |
| REAAQGFLTLMLQGK | 751 | Q7RTU9 | |
| FMRGIEAQFLALQKG | 596 | Q9HCE7 | |
| AIIAGRLRMLGDQFN | 51 | Q5TBC7 | |
| RLRMLGDQFNGELEA | 56 | Q5TBC7 | |
| LLNGLKMGRFERGLS | 136 | Q8N365 | |
| RLLMGDERVKNGLNF | 56 | Q86X95 | |
| EMNGRGELVESLKRF | 131 | Q9Y679 | |
| RSILLRGFDQDMANK | 371 | Q16881 | |
| NMELKVGDFGLAARL | 196 | Q9H4B4 | |
| QDLGDVMKRNEFLRL | 246 | I1YAP6 | |
| NLGAIRQGMKRFQFL | 1176 | Q8N2C7 | |
| KDGRLLPGDRLMFVN | 741 | O75970 | |
| INRFRGRKNMLVKLG | 981 | O60673 | |
| MDLARKEFLRGNGLA | 1 | Q6IEE8 | |
| AQIALQLGRMLEARK | 1101 | P35590 | |
| NLKFMAEVGTNRGLL | 456 | P42226 | |
| NLVNGMLGDKRRVFT | 266 | Q9BX26 | |
| RGKNMEVRLIFLSGL | 281 | Q8TCT8 | |
| GEQLGLFLRTKMGRD | 111 | Q6ZSV7 | |
| ADRAFLQLERKFGRM | 221 | Q9UJ04 | |
| MNDQDGKENRLGLSR | 321 | Q5JSZ5 | |
| IGNMDREFIAERQKG | 81 | Q7Z7A4 | |
| RQFRGAVGEQLGKMR | 166 | Q6ZMU5 | |
| VGTFQRRRGLGDMKL | 706 | Q9Y4R7 | |
| FGGALEMKGRRLDLQ | 791 | Q96AE7 | |
| TNFMEDRRQRKLLGL | 666 | P11388 | |
| MKLFGRAQLEAERNA | 556 | A1YPR0 | |
| DSGEKGRDLRFLMNL | 186 | P04628 | |
| LGQRRARKEGNEFKM | 191 | Q9HA38 | |
| REAAQGFLTLMLQGK | 751 | A6NGW2 | |
| LQALLQFKRKMGARE | 1486 | Q6PGP7 | |
| EDMRKTFREQGLRNG | 706 | Q9NVE5 | |
| MIQQRIKEGGQFLER | 481 | Q9NYI0 | |
| VMLENFRNLLSVGGK | 36 | Q9UK12 | |
| KALMGLQRFREAAAV | 381 | Q49AM3 | |
| FDEQIRKLMGLLGDN | 136 | Q5T230 | |
| GLRLLAQAEDFDQMK | 251 | Q8N8Y2 | |
| DGKLTLMFRVGNLRN | 206 | P48549 | |
| RLLNLRVGDAQGMFE | 481 | Q9UPR5 | |
| KNGLDLGEDARFRMF | 1216 | Q14896 |